AstraZeneca PLC (AZN)

Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca's ETCAMAH™ (camizestrant) in Advanced ER-positive Breast Cancer

Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

Jefferies Financial Group Reaffirms “Buy” Rating for AstraZeneca (LON:AZN)

Jefferies maintains 'buy' rating on AstraZeneca ahead of third-quarter results

Astrazeneca (AZN) Exceeds Market Returns: Some Facts to Consider

Citi raises AstraZeneca target to £186 as tozorakimab prospects improve

AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment

Park National Corp OH Purchases 67,214 Shares of Astrazeneca Plc $AZN

AstraZeneca opens new global strategic R&D center in Kendall Square, Cambridge, Massachusetts

SMMT Inks Deal With AZN-Daiichi to Study Ivonescimab + Datroway Combos

AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics

Biofrontera (NASDAQ:BFRI) & Astrazeneca (NYSE:AZN) Critical Contrast

AstraZeneca Stocks Moves Lower as Datroway Combination Enters Phase 3

AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination

Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway

Daiichi Sankyo and AstraZeneca Enter into Clinical Trial Collaboration with Summit Therapeutics to Evaluate Datroway® in Combination with Ivonescimab Across Multiple Tumor Types

700,000 Seniors Have Started GLP-1s Through Medicare. Now AstraZeneca Just Moved a Once-Daily Pill Into Phase 3

AstraZeneca's $2 Billion Vote of Confidence Leaves Summit Therapeutics Trading Well Below Street Targets

AstraZeneca PLC (AZN) Stock Down 1.2% -- Now Undervalued? GF Score: 78/100